We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A STUDY ON TOPICAL CALCIUM DOBESILATE FOR THE TREATMENT OF LIMITED PLAQUE PSORIASIS.
- Authors
Puri, Neerja; Puri, Asha
- Abstract
Introduction: Topical dobesilate offers the potential for treatment of plaque psoriasis without atrophy or other local side effects associated with the use of topical corticosteroids. Fibroblast growth factor (FGF)-mediated pathways participate in many of the cellular events implicated in the pathogenesis of psoriasis. Thus, targeting FGF signals may be potentially therapeutic. Aims: To study the efficacy of topical calcium dobesilate for the treatment of 50 patients of limited plaque psoriasis. Methods: For the present study, fifty clinically diagnosed cases of psoriasis with limited number of plaques (<5 ) were selected from the outpatient dermatology department. Lesions were treated with potassium dobesilate for a maximal period of 4 weeks. No other modality of treatment was used other than emollients and oral antihistaminics. Results: The mean duration of disease in our study was 4.74 + 14.64 years in our study. The mean reduction in PASI score with topical calcium dobesilate was statistically significant in our study (p > 0.05).
- Subjects
PSORIASIS treatment; ADRENOCORTICAL hormones; ANTIHISTAMINES; DRUG efficacy; FIBROBLAST growth factors
- Publication
Our Dermatology Online / Nasza Dermatologia Online, 2013, Vol 4, Issue 3, p290
- ISSN
2081-9390
- Publication type
Article
- DOI
10.7241/ourd.20133.70